The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Indicators of clinical response to abiraterone acetate (AA) in men with metastatic castration-resistant-prostate-cancer (mCRPC).
Martin Boegemann
No relevant relationships to disclose
Phillip Mikah
No relevant relationships to disclose
Okyaz Eminaga
No relevant relationships to disclose
Edwin Herrmann
No relevant relationships to disclose
Philipp Marius Papavassilis
No relevant relationships to disclose
Axel Semjonow
No relevant relationships to disclose
Laura-Maria Krabbe
No relevant relationships to disclose